ADMINISTRATION OF A COMBINED ORAL CONTRACEPTIVE CONTAINING ESTRADIOL VALERATE/DIENOGEST (E2V/DNG) BY WOMEN WITH MENORRHAGIA
https://doi.org/10.21518/2079-701X-2017-2-31-37
Abstract
Menorrhagia is the pathological condition which is negatively affecting physical, emotional and social quality life of the woman. Medicines of the choice of therapy of uterine bleedings are the combined oral contraceptives (COC). The estradiol valerate/ dienogest (E2V/DNG), represents the combined oral contraceptive (COC) recommended for women as contraceptive. Gives to feature of influence of medicine on endometrium the chance of its application in case of uterine bleedings. The hormones which are a part suppress excessive proliferation of endometrium that leads to reduction of amount of menstrual allocations. Results of a research which confirm successful application of E2V/DNG in case of the menorrhagia at the women of reproductive age in clinical situations who aren’t requiring operational treatment are provided.
About the Authors
E. R. Dovlethanova
Scientific Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov, MoH RF
Russian Federation
Russian Federation
PhD in Medicine
E. A. Mezhevitinova
Scientific Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov, MoH RF
Russian Federation
Russian Federation
MD
A. N. Mgeryan
Scientific Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov, MoH RF
Russian Federation
Russian Federation
PhD in Medicine
P. R. Abakarova
Scientific Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov, MoH RF
Russian Federation
Russian Federation
PhD in Medicine
References
1. Руководство по амбулаторно-поликлинической помощи в акушерстве и гинекологии. Под редакцией В.Н. Серова, Г.Т. Сухих, В.Н. Прилепской, В.Е. Радзинского. 3-е издание, переработанное и дополненное, ГЭОТАР-Медиа. 2016: 885-894.
2. Heavy Menstrual Bleeding. Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. https://www.cdc.gov/ncbddd/women/menorrhagia.html/
3. Fast Facts for Your Health: Menorrhagia. National Women’s Health Resource Center (NWHRC), Washington, D.C. http://www.healthywomen.org.
4. Menstruation: Heavy Bleeding (Menorrhagia). PreventDisease.com. http://preventdisease.com/diseases/menstruation_heavy_bleeding.html
5. Клинические рекомендации «Акушерство и гинекология». Под редакцией Г.М. Савельевой, В.Н. Серова, Г.Т. Сухих. 4-е издание, переработанное и дополненное, ГЭОТАР-Медиа, 2016, 1024 с.
6. Прилепская В.Н., Межевитинова Е.А., Назарова Н.М. и др. Гормональная контрацепция. Москва, ГЭОТАР-Медиа, 2011, 256 с.
7. Women with Inherited Bleeding Disorders: Surgical Options for Menorrhagia. Canadian Hemophilia Society. http://www.hemophilia.ca/en/2.5.5.php.
8. Munro M.G., Critchley H.O., Broder M.S. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductiveage. FIGO Working Group on Menstrual Disorders. Int J Gynaecol Obstet, 2011, 113: 3–13.
9. National Collaborating Centre for Women’s and Children’s Health. National Institute for Health and Clinical Excellence (NICE). Heavy menstrual bleeding. London: Royal College of Obstetricians and Gynaecologists Press, 2007.
10. Heavy menstrual bleeding. Clinical guideline 44. London National Institute for Health and Clinical Excellence. January 2007.
11. Heavy menstrual bleeding. Quality standard. NICE /nice.org.uk/guidance/qs47. 2013.
12. World Health Organization. Medical eligibility criteria for contraceptive use. 3rd ed. Geneva: World Health Organization, 2004.
13. Phillip CS, Faiz A, Dowling NF, Beckman M, Owens S, Ayers C, Bachmann G. Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation. American Journal of Obstetrics & Gynecology, 2008, 198: 163.e1–163.e8.
14. Apgar BS, Kaufman AH, George-Nwogu U, Kittendorf A. Treatment of menorrhagia. American Family Physician, 2007, 75: 1813-1820. http://www.aafp.org/afp/20070615/1813.html.
15. Heavy Bleeding and Endometrial Ablation. FertilityAnswers.com. http://www.fertilityanswers.com/endometrial_ablation.htm.
16. Menorrhagia (heavy menstrual bleeding). MayoClinic.com Health Library. http://www.riverside-online.com/health_reference/WomensHealth/DS00394.cfm.
17. De Leoa V, Fruzzettib F, Musacchioa MC, Scolaroa V, Di Sabatinoa A, Morgantea G. Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism. Contraception, 2013, 88: 364–368.
18. Higham JM, O’Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. British Journal of Obstetrics and Gynaecology, 1990, 97: 734–739.
19. Межевитинова Е.А., Бурлев В.А., Набиева К.Р., Ильясова Н.А., Иноземцева Е.А. Комплексная оценка эффективности, переносимости и безопасности комбинированного гормонального контрацептива третьего поколения. Медицинский совет, 2015, 9: 54-61.
Review
For citations:
Dovlethanova ER, Mezhevitinova EA, Mgeryan AN, Abakarova PR. ADMINISTRATION OF A COMBINED ORAL CONTRACEPTIVE CONTAINING ESTRADIOL VALERATE/DIENOGEST (E2V/DNG) BY WOMEN WITH MENORRHAGIA. Meditsinskiy sovet = Medical Council. 2017;(2):31-37. (In Russ.) https://doi.org/10.21518/2079-701X-2017-2-31-37
Views:
657
Email this article 